"Patient blood management" in orthopaedic surgery;"Patient blood management" en cirugía ortopédica

Revista Espanola de Cirugia Ortopedica y Traumatologia

Volumn 59, Issue 3, 2015, Pages 137-149

  Canillas, Fernando ^a   Gómez Ramírez, Susana ^b   García Erce, José Antonio ^c   Pavía Molina, José ^b   Gómez Luque, Aurelio ^d   Muñoz, Manuel ^b  

^a Cruz Roja Central Hospital   (Spain)

^b UNIVERSIDAD DE MÁLAGA   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Allogeneic blood transfusion; Anaemia; Antifibrinolytic agents; Autologous blood transfusion; Erythropoiesis stimulating agents; Iron; Orthopedic surgery; Patient blood management; Surgical blood loss

Indexed keywords

ANTIANEMIC AGENT;

BLOOD AUTOTRANSFUSION; BLOOD LOSS, SURGICAL; BLOODLESS CARE; HUMAN; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PROCEDURES;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; BLOODLESS MEDICAL AND SURGICAL PROCEDURES; HEMATINICS; HUMANS; ORTHOPEDIC PROCEDURES; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 84928061614     PISSN: 18884415     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.recot.2014.11.005     Document Type: Short Survey

References (55)

1. Rosencher N., Kerkkamp H.E., Macheras G., Munuera L.M., Menichella G., Barton D.M., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43:459-469.
2. Gombotz H., Rehak P.H., Shander A., Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007, 47:1468-1480.
3. Quijada J.L., Hurtado P., de Lamo J. Factores que incrementan el riesgo de transfusión sanguínea en los pacientes con fractura de cadera. Rev Ortp Traumatol. 2011, 55:35-38.
4. Muñoz M., García-Erce J.A., Campos A., Fernando Barrios L. Marco legal del uso de sangre autóloga y otras alternativas a la transfusión alogénica. Med Clin (Barc) 2007, 128:256-262.
5. Isbister J.P. The three-pillar matrix of patient blood management--an overview. Best Pract Res Clin Anaesthesiol 2013, 27:69-84.
6. Leal-Noval S.R., Muñoz M., Asuero M., Contreras E., García-Erce J.A., Llau J.V., et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the Seville Document. Blood Transfus 2013, 11:585-610.
7. Kozek-Langenecker S.A., Afshari A., Albaladejo P., Santullano C.A., De Robertis E., Filipescu D.C., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013, 30:270-382.
8. Carson J.L., Grossman B.J., Kleinman S., Tinmouth A.T., Marques M.B., Fung M.K., et al. Red Blood Cell Transfusion: A Clinical Practice Guideline from the AABB. Ann Intern Med 2012, 157:49-58.
9. Rohde J.M., Dimcheff D.E., Blumberg N., Saint S., Langa K.M., Kuhn L., et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014, 311:1317-1326.
10. Sangüesa-Nebot M.J. F Cabanes-Soriano F. Resultados de la encuesta sobre práctica transfusional entre traumatólogos-ortopedas en España. Rev Ortp Traumatol 2004, 48:449-454.
11. Leal-Noval S.R., Muñoz-Gómez M., Jiménez-Sánchez M., Cayuela A., Leal-Romero M., Puppo-Moreno A., et al. Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit. Intensive Care Med 2013, 39:445-453.
12. Spahn D.R. Anemia and patient blood management in hip and knee surgery. A systematic review of the literature. Anesthesiology 2010, 113:482-495.
13. Jans Ø., Jørgensen C., Kehlet H., Johansson P.I. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2014, 54:717-726. Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group.
14. Goodnough L.T., Maniatis A., Earnshaw P., Benoni G., Beris P., Bisbe E., et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011, 106:13-22.
15. Bisbe E., García-Erce J.A., Díez-Lobo A.I., Muñoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011, 107:477-478. Anaemia Working Group España.
16. Muñoz M., Gómez-Ramírez S., Martín-Montañez E., Naveira E., Seara J., Pavía J. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfus 2014, 12:40-49.
17. Bisbe E., Moltó L., Arroyo R., Muniesa J.M., Tejero M. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 2014, 113:402-409.
18. European Medicines Agency New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines [consultado 18 Jun 2014]. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/newsdetail_001833.jsp&mid=WC0b01ac058004d5c1.
19. Litton E., Xiao J., Ho K.M. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013, 347:f4822.
20. Kulnigg-Dabsch S., Evstatiev R., Dejaco C., Gasche C. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS One 2012, 7:e34520.
21. Rosencher N., Poisson D., Albi A., Aperce M., Barré J., Samama C.M. Two injections of erythropoietin (EPO) correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth 2005, 52:160-165.
22. Moreno Zurriarían E., Echenique Elizondo M., Emparanza Knorr J.I., Usabiaga Zarranz J. Cirugía sin sangre en las prótesis totales de rodilla. Rev Ortp Traumatol. 2008, 52:372-380.
23. Basora M., Colomina M.J., Tio M., Mora L., Salazar F., Ciercoles E. Optimizing preoperative haemoglobin with intravenous iron. Br J Anaesth 2013, 110:488-490.
24. Theusinger O.M., Kind S.L., Seifert B., Borgeat L., Gerber C., Spahn D.R. Patient Blood Management in Orthopaedic surgery-a four year follow up from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland on transfusion requirements and blood loss. Blood Transfusion 2014, 12:195-203.
25. Muñoz M., Gómez-Ramírez S., Cuenca J., García-Erce J.A., Iglesias-Aparicio D., Haman-Alcober S., et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014, 54:289-299.
26. Alsaleh K., Alotaibi G.S., Almodaimegh H.S., Aleem A.A., Kouroukis C.T. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. J Arthroplasty 2013, 28:1463-1472.
27. th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(2 Suppl):7S-47S.
28. López-Anglada E., Paz-Aparicio J., Bertrand D., Gosálbez J., Núñez-Batalla D., Paz-Jiménez J. Influencia de la aprotinina en el sangrado postoperatorio de la artroplastia total de rodilla. Rev Ortp Traumatol 2005, 49:421-428.
29. López-Anglada Fernández E., García Villabrille S., Fernández Bances I., Paz Aparicio J., Bertrand Álvarez D., Pena Vázquez J., et al. Utilización de aprotinina como agente hemostático en la prótesis total de cadera. Rev Ortp Traumatol 2006, 50:307-317.
30. Ficha técnica Amchafibrin 500mg solución inyectable [consultado 4 Jun 2014]. Disponible en: http://aemps.es/cima/pdfs/es/ft/53939/FT_53939.pdf.
31. Agencia Española del Medicamento y Productos Sanitarios. Utilización de medicamentos ya autorizados en condiciones diferentes a las establecidas en su ficha técnica [consultado 18 Jun 2014]. Disponible en: http://www.aemps.gob.es/medicamentosUsoHumano/medSituacionesEspeciales/instruccTramitacion.htm.
32. Aguilera-Roig X., Jordán-Sales M., Natera-Cisneros L., Monllau-García J.C., Martínez-Zapata M.J. Ácido tranexámico en cirugía ortopédica. Rev Esp Cir Ortop Traumatol 2014, 58:52-56.
33. Shakur H., Roberts I., Bautista R., Caballero J., Coats T., Dewan Y., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010, 376:23-32. CRASH-2 trial collaborators.
34. Muñoz M., Páramo J.A. Antifibrinolytic agents in current anaesthetic practice: use of tranexamic acid in lower limb arthroplasty. Br J Anesth 2014, 112:766-767.
35. Zufferey P.J., Miquet M., Quenet S., Martin P., Adam P., Albaladejo P., et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth. 2010, 104:23-30.
36. Huang F., Wu D., Ma G., Yin Z., Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res 2014, 186:318-327.
37. Charles I., Górriz R., López M., Coderch J. Ácido tranexámico intravenoso en la artroplastia total primaria de rodilla. Med Clin (Barc) 2014, 143:421-422.
38. Wang H., Shan L., Zeng H., Sun M., Hua Y., Cai Z. Is fibrin sealant effective and safe in total knee arthroplasty? A meta-analysis of randomized trials. J Orthop Surg Res 2014, 9:36.
39. Informe de AEMPs sobre el uso de plasma rico en plaquetas. Informe/IV/23052013 [consultado 18 Jun 2014]. Disponible en: http://www.aemps.gob.es/medicamentosUsoHumano/medSituaciones Especiales/docs/PRP-AEMPS-DEF-mayo13.pdf.
40. Parker M.J., Livingstone V., Clifton R., McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev 2007, CD001825.
41. Slappendel R., Horstmann W., Dirksen R., van Hellemondt G.G. Wound drainage with or without blood salvage? An open, prospective, randomized, single center comparison of blood loss, postoperative hemoglobin levels and allogeneic blood transfusions after major hip surgery. Transfus Altern Transfus Med 2008, 10:174-181.
42. Muñoz M., Iglesias D., Garcia-Erce J.A., Cuenca J., Herrera A., Martin-Montañez E., et al. Utility and cost of low-vacuum reinfusion drains in patients undergoing surgery for subcapital hip fracture repair. A before and after cohort study. Vox Sang 2014, 106:83-91.
43. Di Martino A., Tirindelli M.C., Migliaccio M., Fossati C., Cancilleri F., Avvisati G., et al. La función de la eritropoyetina en pacientes sometidos a artroplastia articular electiva y a donación de sangre autóloga preoperatoria. Rev Esp Cir Ortop Traumatol 2007, 51:319-324.
44. Bennett J., Haynes S., Torella F., Grainger H., McCollum C. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion 2006, 46:1097-1103.
45. Sebastián Bueno C. Ferrer Lariño C, Sánchez Arrieta Y, García Vallejo JJ, Mérida de la Torre FJ, Morell Ocaña M, et al. Recuperación de sangre intra y postoperatoria en cirugía ortopédica. Rev Ortp Traumatol 1999, 43:175-180.
46. Sebastián C., Romero R., Olalla E., García-Vallejo J.J., Gutiérrez J., Muñoz M. Autotransfusión en cirugía de columna lumbar. Rev Ortp Traumatol 2001, 45:502-511.
47. Zarza-Pérez A., Hernández-Cortés P. Eficacia del uso del drenaje de autotransfusión en la cirugía primaria de prótesis de cadera y rodilla. Rev Ortp Traumatol 2005, 49:187-192.
48. Muñoz M., Slappendel R., Thomas D. Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion. Blood Transfus 2011, 9:248-261.
49. Horstmann W.G., Slappendel R., Van Hellemondt G.G., Castelein R.M., Verheyen C.C.P.M. Safety of retransfusion of filtered shed blood in 1819 patients after total hip or knee arthroplasty. Tranfus Altern Tranfus Med 2010, 11:57-64.
50. Jansson J-R, Slappendel R. Local infiltration analgesia (LIA) and postoperative blood salvage can be safely combined in major orthopedic surgery [Poster]. 30th Annual ESRA Congress, Dresden (Germany), September 2011 [consultado 18 Jun 2014]. Disponible en: http://www.multiwebcast.com/eposter.esra/2011/30th/12427/.
51. Thomassen B.J.W., Pool L., Vander Flier R., Van der Flier R., Stienstra R. in'T Velt B.A. Safety of retransfusing shed blood after local infiltration analgesia in total knee arthroplasty. Acta Orthop Belg 2012, 78:506-511.
52. Knudsen K., Beckman S.M., Blomberg S., Sjövall J., Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997, 78:507-514.
53. Muñoz M., Ariza D., Campos A., Martín-Montañez E., Pavía J. The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. Blood Transfus 2013, 11:260-271.
54. Kotzé A., Carter L.A., Scally A.J. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012, 108:943-952.
55. Shander A., Javidroozi M., Perelman S., Puzio T., Lobel G. From Bloodless Surgery to Patient Blood Management. Mount Sinai J Med 2012, 79:56-65.